Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Operating Margin (2020 - 2022)

Historic Operating Margin for Immuneering (IMRX) over the last 3 years, with Q4 2022 value amounting to 3073627.91%.

  • Immuneering's Operating Margin fell 30677648900.0% to 3073627.91% in Q4 2022 from the same period last year, while for Sep 2023 it was 12328770.77%, marking a year-over-year decrease of 123191132400.0%. This contributed to the annual value of 16325.77% for FY2022, which is 146966100.0% down from last year.
  • Latest data reveals that Immuneering reported Operating Margin of 3073627.91% as of Q4 2022, which was down 30677648900.0% from 34362.04% recorded in Q3 2022.
  • Over the past 5 years, Immuneering's Operating Margin peaked at 644.66% during Q3 2020, and registered a low of 3073627.91% during Q4 2022.
  • Its 3-year average for Operating Margin is 285392.02%, with a median of 1772.01% in 2021.
  • Its Operating Margin has fluctuated over the past 5 years, first tumbled by -4606000bps in 2021, then tumbled by 2000000000bps in 2022.
  • Immuneering's Operating Margin (Quarter) stood at 877.56% in 2020, then tumbled by -568bps to 5863.02% in 2021, then plummeted by -52324bps to 3073627.91% in 2022.
  • Its Operating Margin stands at 3073627.91% for Q4 2022, versus 34362.04% for Q3 2022 and 12334.43% for Q2 2022.